Conv. Plasma
Nigella Sativa
Peg.. Lambda

All vitamin D studies
Meta analysis
Home COVID-19 treatment researchVitamin DVitamin D (more..)
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta
Cannabidiol Meta Molnupiravir Meta
Colchicine Meta
Conv. Plasma Meta
Curcumin Meta Nigella Sativa Meta
Ensovibep Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Peg.. Lambda Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Ivermectin Meta
Lactoferrin Meta

All Studies   Meta Analysis   Recent:  
0 0.5 1 1.5 2+ Death at day 26 71% Improvement Relative Risk Death at day 10 90% Vitamin D for COVID-19  Carpagnano et al.  Sufficiency Are vitamin D levels associated with COVID-19 outcomes? Retrospective 42 patients in Italy Lower mortality with higher vitamin D levels (p=0.05) Carpagnano et al., J. Endocrinol. Inve.., Aug 2020 Favors vitamin D Favors control

Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19

Carpagnano et al., J. Endocrinol. Invest., 2020, Aug 9, 1-7, doi:10.1007/s40618-020-01370-x
Aug 2020  
  Source   PDF   All Studies   Meta AnalysisMeta
Retrospective study 42 patients with acute respiratory failure, 81% with low vitamin D levels.
After 10 days, patients with severe vitamin D deficiency had a 50% probability of dying, while those with vitamin D ≥ 10 ng/mL had a 5% mortality risk, RR 0.1, p = 0.019.
This is the 8th of 184 COVID-19 sufficiency studies for vitamin D, which collectively show higher levels reduce risk with p<0.0000000001 (1 in 712 vigintillion).
risk of death at day 26, 70.6% lower, RR 0.29, p = 0.0499, high D levels 5 of 34 (14.7%), low D levels 4 of 8 (50.0%), NNT 2.8, >30 ng/mL.
risk of death at day 10, 90.0% lower, RR 0.10, p = 0.02, high D levels 2 of 34 (5.9%), low D levels 4 of 8 (50.0%), NNT 2.3, adjusted per study, >30 ng/mL.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Carpagnano et al., 9 Aug 2020, retrospective, Italy, peer-reviewed, 10 authors.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperVitamin DAll
Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19
G E Carpagnano, V Di Lecce, V N Quaranta, A Zito, E Buonamico, E Capozza, A Palumbo, G Di Gioia, V N Valerio, O Resta
Journal of Endocrinological Investigation, doi:10.1007/s40618-020-01370-x
Purpose Hypovitaminosis D is a highly spread condition correlated with increased risk of respiratory tract infections. Nowadays, the world is in the grip of the Coronavirus disease 19 (COVID 19) pandemic. In these patients, cytokine storm is associated with disease severity. In consideration of the role of vitamin D in the immune system, aim of this study was to analyse vitamin D levels in patients with acute respiratory failure due to COVID-19 and to assess any correlations with disease severity and prognosis. Methods In this retrospective, observational study, we analysed demographic, clinical and laboratory data of 42 patients with acute respiratory failure due to COVID-19, treated in Respiratory Intermediate Care Unit (RICU) of the Policlinic of Bari from March, 11 to April 30, 2020. Results Eighty one percent of patients had hypovitaminosis D. Based on vitamin D levels, the population was stratified into four groups: no hypovitaminosis D, insufficiency, moderate deficiency, and severe deficiency. No differences regarding demographic and clinical characteristics were found. A survival analysis highlighted that, after 10 days of hospitalization, severe vitamin D deficiency patients had a 50% mortality probability, while those with vitamin D ≥ 10 ng/mL had a 5% mortality risk (p = 0.019). Conclusions High prevalence of hypovitaminosis D was found in COVID-19 patients with acute respiratory failure, treated in a RICU. Patients with severe vitamin D deficiency had a significantly higher mortality risk. Severe vitamin D deficiency may be a marker of poor prognosis in these patients, suggesting that adjunctive treatment might improve disease outcomes.
Author contributions GEC and VDL, made substantial contribution to the conception and design of the work, VDL, EB, EC, GDG, AP, VNV to the data acquisition, VDL, EC, VQ, to the analysis, and VQ, AZ, GEC, OR to the interpretation. GEC, VDL, EB, VQ, EC helped in drafting the article and OR revised it critically for important intellectual content. All authors gave the final approval of the version to be published and agreed for the accuracy or integrity of any part of the work. Funding This research did not receive any specific grant from any funding agency in the public, commercial or not-for-profit sector. Availability of data and material The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request. Compliance with ethical standards Conflict of interest All authors disclose no interests related to the present work. Ethics approval The study was approved by the Institutional Review Board of Teaching Hospital Policlinico of Bari (Ethical Committee No. 6380). The procedures used in this study adhere to the tenets of the Declaration of Helsinki. Research involving human participants and/or animals The study was approved by our local ethical committee and informed consent was obtained. Informed consent Informed consent was obtained from all individual participants included in the study. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which..
Chalmers, Mchugh, Docherty, Govan, Hill, Vitamin-D deficiency is associated with chronic bacterial colonisation and disease severity in bronchiectasis, Thorax
Chen, Zhang, Ge, Du, Deb et al., Vitamin D receptor inhibits nuclear factor kappa b activation by interacting with ikappab kinase beta protein, J Biol Chem
Dancer, Parekh, Lax, Souza, Zheng et al., Vitamin D deficiency contributes directly to the acute respiratory distress syndrome (ARDS), Thorax
Grant, Lahore, Mcdonnell, Baggerly, French et al., Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths, Nutrients
Holick, The vitamin D deficiency pandemic: approaches for diagnosis, treatment and prevention, Rev Endocr Metab Disord
Hossein-Nezhad, Holick, Optimize dietary intake of vitamin D: an epigenetic perspective, Curr Opin Clin Nutr Metab Care
Huang, Wang, Li, Ren, Zhao et al., Clinical features of patients infected with 2019 novel coronavirus in Wuhan China, Lancet, doi:10.1016/S0140-6736(20)30183-5
Ilie, Stefanescu, Smith, The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality, Aging Clin Exp Res
Lehouck, Mathieu, Carremans, Baeke, Verhaegen et al., High doses of vitamin D to reduce exacerbations in chronic obstructive pulmonary disease: a randomized trial, Ann Intern Med
Lips, Cashman, Lamberg-Allardt, Bischoff-Ferrari, Obermayer-Pietsch et al., Bouillon R on behalf of the Working Group on Vitamin D of the European Calcified Tissue Society (2019) Current Vitamin D Status in European and Middle East Countries and Strategies to Prevent Vitamin D Deficiency: A Position Statement of the European Calcified Tissue Society, Eur J Endocrinol
Liu, Stenger, Li, Wenzel, Tan et al., Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response, Science
Mamani, Muceli, Basir, Vasheghani, Poorolajal, Association between serum concentration of 25-hydroxyvitamin D and community-acquired pneumonia: a case-control study, Int J Gen Med
Martineau, Jolliffe, Greenberg, Aloia, Bergman et al., Vitamin D supplementation to prevent acute respiratory infections: individual participant data meta-analysis, Health Technol Assess
Panfili, Roversi, Argenio, Rossi, Cappa et al., Possibile role of vitamin D in Covid-19 infection in pediatric population, J Endocrinol Invest
Vincent, Moreno, Takala, Willatts, Mendonça et al., The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine, Intensive Care Med
Wang, Nestel, Bourdeau, Nagai, Wang et al., Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression, J Immunol
Yang, Yu, Xu, Shu, Xia et al., Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study, Lancet Respir Med, doi:10.1016/S2213-2600(20)30079-5
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop